Bendectin is a medication that was once prescribed to pregnant women to help prevent birth defects. However, it was taken off the market in 1983 after being linked to birth defects. In this article, we will discuss Bendectin and its history, as well as the current research on the medication and its effects on pregnant women.
Bendectin was first approved by the FDA in 1956. It was originally prescribed as a morning sickness medication, but it was later found to be effective in preventing birth defects. Bendectin is a combination of two drugs, pyridoxine, and doxylamine, which are both safe for pregnant women. Bendectin was taken off the market in 1983 after being linked to birth defects, including limb reduction defects and heart defects.
There have been several studies conducted on Bendectin and its effects on pregnant women. Most of these studies have found that Bendectin does not increase the risk of birth defects. However, one study did find an increased risk of limb reduction defects with Bendectin exposure.
In conclusion, Bendectin is a safe and effective medication for pregnant women. There is no evidence that Bendectin increases the risk of birth defects. If you are pregnant and have any questions about Bendectin, please talk to your doctor.
We hope this information on Bendectin and birth defects was helpful.